 | • レポートコード：QYR2104Z1816 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、糖尿病用装置・治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（糖尿病治療薬、糖尿病治療薬）、用途別市場規模（診断/クリニック、ICU、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・糖尿病用装置・治療薬の市場動向 ・企業の競争状況、市場シェア ・糖尿病用装置・治療薬の種類別市場規模（糖尿病治療薬、糖尿病治療薬） ・糖尿病用装置・治療薬の用途別市場規模（診断/クリニック、ICU、在宅医療） ・糖尿病用装置・治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病用装置・治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病用装置・治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病用装置・治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病用装置・治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Medtronic、BD、Johnson & Johnson、Abbott Laboratories、Novo Nordisk、Bristol-Myers Squibb、DexCom、Companion Medical、GlaxoSmithKline、Glenmark Pharmaceuticals、Novartis、Roche、Sanofi、MSD、Astrazeneca、Takeda、North China Pharmaceutical Group Corporation、Huadong Medicine、Dongbao Pharmaceutical、Hisun Pharmacy、KELUN、Ginwa、Tianan Pharmaceutical） ・結論 |
Market Analysis and Insights: Global Diabetes Devices and Drugs Market
The global Diabetes Devices and Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Devices and Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Devices and Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Devices and Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Devices and Drugs market.
Global Diabetes Devices and Drugs Scope and Market Size
Diabetes Devices and Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Devices and Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Diabetes Devices
Diabetes Drugs
Segment by Application
Diagnostic/Clinics
ICUs
Home Healthcare
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Medtronic
BD
Johnson & Johnson
Abbott Laboratories
Novo Nordisk
Bristol-Myers Squibb
DexCom
Companion Medical
GlaxoSmithKline
Glenmark Pharmaceuticals
Novartis
Roche
Sanofi
MSD
Astrazeneca
Takeda
North China Pharmaceutical Group Corporation
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Devices and Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diabetes Devices
1.2.3 Diabetes Drugs
1.3 Market by Application
1.3.1 Global Diabetes Devices and Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Devices and Drugs Market Perspective (2016-2027)
2.2 Diabetes Devices and Drugs Growth Trends by Regions
2.2.1 Diabetes Devices and Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Devices and Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Devices and Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Devices and Drugs Industry Dynamic
2.3.1 Diabetes Devices and Drugs Market Trends
2.3.2 Diabetes Devices and Drugs Market Drivers
2.3.3 Diabetes Devices and Drugs Market Challenges
2.3.4 Diabetes Devices and Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Devices and Drugs Players by Revenue
3.1.1 Global Top Diabetes Devices and Drugs Players by Revenue (2016-2021)
3.1.2 Global Diabetes Devices and Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Devices and Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Devices and Drugs Revenue
3.4 Global Diabetes Devices and Drugs Market Concentration Ratio
3.4.1 Global Diabetes Devices and Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Devices and Drugs Revenue in 2020
3.5 Diabetes Devices and Drugs Key Players Head office and Area Served
3.6 Key Players Diabetes Devices and Drugs Product Solution and Service
3.7 Date of Enter into Diabetes Devices and Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Devices and Drugs Breakdown Data by Type
4.1 Global Diabetes Devices and Drugs Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Devices and Drugs Forecasted Market Size by Type (2022-2027)
5 Diabetes Devices and Drugs Breakdown Data by Application
5.1 Global Diabetes Devices and Drugs Historic Market Size by Application (2016-2021)
5.2 Global Diabetes Devices and Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Diabetes Devices and Drugs Market Size (2016-2027)
6.2 North America Diabetes Devices and Drugs Market Size by Type
6.2.1 North America Diabetes Devices and Drugs Market Size by Type (2016-2021)
6.2.2 North America Diabetes Devices and Drugs Market Size by Type (2022-2027)
6.2.3 North America Diabetes Devices and Drugs Market Size by Type (2016-2027)
6.3 North America Diabetes Devices and Drugs Market Size by Application
6.3.1 North America Diabetes Devices and Drugs Market Size by Application (2016-2021)
6.3.2 North America Diabetes Devices and Drugs Market Size by Application (2022-2027)
6.3.3 North America Diabetes Devices and Drugs Market Size by Application (2016-2027)
6.4 North America Diabetes Devices and Drugs Market Size by Country
6.4.1 North America Diabetes Devices and Drugs Market Size by Country (2016-2021)
6.4.2 North America Diabetes Devices and Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Diabetes Devices and Drugs Market Size (2016-2027)
7.2 Europe Diabetes Devices and Drugs Market Size by Type
7.2.1 Europe Diabetes Devices and Drugs Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Devices and Drugs Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Devices and Drugs Market Size by Type (2016-2027)
7.3 Europe Diabetes Devices and Drugs Market Size by Application
7.3.1 Europe Diabetes Devices and Drugs Market Size by Application (2016-2021)
7.3.2 Europe Diabetes Devices and Drugs Market Size by Application (2022-2027)
7.3.3 Europe Diabetes Devices and Drugs Market Size by Application (2016-2027)
7.4 Europe Diabetes Devices and Drugs Market Size by Country
7.4.1 Europe Diabetes Devices and Drugs Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Devices and Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Devices and Drugs Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Type
8.2.1 Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Devices and Drugs Market Size by Application
8.3.1 Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetes Devices and Drugs Market Size by Region
8.4.1 Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Devices and Drugs Market Size (2016-2027)
9.2 Latin America Diabetes Devices and Drugs Market Size by Type
9.2.1 Latin America Diabetes Devices and Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Devices and Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Devices and Drugs Market Size by Type (2016-2027)
9.3 Latin America Diabetes Devices and Drugs Market Size by Application
9.3.1 Latin America Diabetes Devices and Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Diabetes Devices and Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Diabetes Devices and Drugs Market Size by Application (2016-2027)
9.4 Latin America Diabetes Devices and Drugs Market Size by Country
9.4.1 Latin America Diabetes Devices and Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Devices and Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Devices and Drugs Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Type
10.2.1 Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Devices and Drugs Market Size by Application
10.3.1 Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetes Devices and Drugs Market Size by Country
10.4.1 Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Diabetes Devices and Drugs Introduction
11.1.4 Medtronic Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.1.5 Medtronic Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Diabetes Devices and Drugs Introduction
11.2.4 BD Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.2.5 BD Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Diabetes Devices and Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Diabetes Devices and Drugs Introduction
11.4.4 Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Details
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Diabetes Devices and Drugs Introduction
11.5.4 Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.5.5 Novo Nordisk Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Introduction
11.6.4 Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 DexCom
11.7.1 DexCom Company Details
11.7.2 DexCom Business Overview
11.7.3 DexCom Diabetes Devices and Drugs Introduction
11.7.4 DexCom Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.7.5 DexCom Recent Development
11.8 Companion Medical
11.8.1 Companion Medical Company Details
11.8.2 Companion Medical Business Overview
11.8.3 Companion Medical Diabetes Devices and Drugs Introduction
11.8.4 Companion Medical Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.8.5 Companion Medical Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Diabetes Devices and Drugs Introduction
11.9.4 GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.9.5 GlaxoSmithKline Recent Development
11.10 Glenmark Pharmaceuticals
11.10.1 Glenmark Pharmaceuticals Company Details
11.10.2 Glenmark Pharmaceuticals Business Overview
11.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Introduction
11.10.4 Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.10.5 Glenmark Pharmaceuticals Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Diabetes Devices and Drugs Introduction
11.11.4 Novartis Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.11.5 Novartis Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Diabetes Devices and Drugs Introduction
11.12.4 Roche Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.12.5 Roche Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Diabetes Devices and Drugs Introduction
11.13.4 Sanofi Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.13.5 Sanofi Recent Development
11.14 MSD
11.14.1 MSD Company Details
11.14.2 MSD Business Overview
11.14.3 MSD Diabetes Devices and Drugs Introduction
11.14.4 MSD Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.14.5 MSD Recent Development
11.15 Astrazeneca
11.15.1 Astrazeneca Company Details
11.15.2 Astrazeneca Business Overview
11.15.3 Astrazeneca Diabetes Devices and Drugs Introduction
11.15.4 Astrazeneca Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.15.5 Astrazeneca Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Diabetes Devices and Drugs Introduction
11.16.4 Takeda Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.16.5 Takeda Recent Development
11.17 North China Pharmaceutical Group Corporation
11.17.1 North China Pharmaceutical Group Corporation Company Details
11.17.2 North China Pharmaceutical Group Corporation Business Overview
11.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Introduction
11.17.4 North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.17.5 North China Pharmaceutical Group Corporation Recent Development
11.18 Huadong Medicine
11.18.1 Huadong Medicine Company Details
11.18.2 Huadong Medicine Business Overview
11.18.3 Huadong Medicine Diabetes Devices and Drugs Introduction
11.18.4 Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.18.5 Huadong Medicine Recent Development
11.18 Dongbao Pharmaceutical
.1 Dongbao Pharmaceutical Company Details
.2 Dongbao Pharmaceutical Business Overview
.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Introduction
.4 Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2016-2021)
.5 Dongbao Pharmaceutical Recent Development
11.20 Hisun Pharmacy
11.20.1 Hisun Pharmacy Company Details
11.20.2 Hisun Pharmacy Business Overview
11.20.3 Hisun Pharmacy Diabetes Devices and Drugs Introduction
11.20.4 Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.20.5 Hisun Pharmacy Recent Development
11.21 KELUN
11.21.1 KELUN Company Details
11.21.2 KELUN Business Overview
11.21.3 KELUN Diabetes Devices and Drugs Introduction
11.21.4 KELUN Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.21.5 KELUN Recent Development
11.22 Ginwa
11.22.1 Ginwa Company Details
11.22.2 Ginwa Business Overview
11.22.3 Ginwa Diabetes Devices and Drugs Introduction
11.22.4 Ginwa Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.22.5 Ginwa Recent Development
11.23 Tianan Pharmaceutical
11.23.1 Tianan Pharmaceutical Company Details
11.23.2 Tianan Pharmaceutical Business Overview
11.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Introduction
11.23.4 Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2016-2021)
11.23.5 Tianan Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Diabetes Devices and Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diabetes Devices
Table 3. Key Players of Diabetes Drugs
Table 4. Global Diabetes Devices and Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Diabetes Devices and Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Diabetes Devices and Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Diabetes Devices and Drugs Market Share by Regions (2016-2021)
Table 8. Global Diabetes Devices and Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Diabetes Devices and Drugs Market Share by Regions (2022-2027)
Table 10. Diabetes Devices and Drugs Market Trends
Table 11. Diabetes Devices and Drugs Market Drivers
Table 12. Diabetes Devices and Drugs Market Challenges
Table 13. Diabetes Devices and Drugs Market Restraints
Table 14. Global Diabetes Devices and Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Diabetes Devices and Drugs Market Share by Players (2016-2021)
Table 16. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Devices and Drugs as of 2020)
Table 17. Ranking of Global Top Diabetes Devices and Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Diabetes Devices and Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Diabetes Devices and Drugs Product Solution and Service
Table 21. Date of Enter into Diabetes Devices and Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Diabetes Devices and Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Diabetes Devices and Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Diabetes Devices and Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Diabetes Devices and Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Diabetes Devices and Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Diabetes Devices and Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Diabetes Devices and Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Diabetes Devices and Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Diabetes Devices and Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Diabetes Devices and Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Diabetes Devices and Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Diabetes Devices and Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Diabetes Devices and Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Diabetes Devices and Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diabetes Devices and Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Medtronic Company Details
Table 62. Medtronic Business Overview
Table 63. Medtronic Diabetes Devices and Drugs Product
Table 64. Medtronic Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 65. Medtronic Recent Development
Table 66. BD Company Details
Table 67. BD Business Overview
Table 68. BD Diabetes Devices and Drugs Product
Table 69. BD Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 70. BD Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Diabetes Devices and Drugs Product
Table 74. Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Abbott Laboratories Company Details
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Diabetes Devices and Drugs Product
Table 79. Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 80. Abbott Laboratories Recent Development
Table 81. Novo Nordisk Company Details
Table 82. Novo Nordisk Business Overview
Table 83. Novo Nordisk Diabetes Devices and Drugs Product
Table 84. Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 85. Novo Nordisk Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Diabetes Devices and Drugs Product
Table 89. Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. DexCom Company Details
Table 92. DexCom Business Overview
Table 93. DexCom Diabetes Devices and Drugs Product
Table 94. DexCom Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 95. DexCom Recent Development
Table 96. Companion Medical Company Details
Table 97. Companion Medical Business Overview
Table 98. Companion Medical Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 99. Companion Medical Recent Development
Table 100. GlaxoSmithKline Company Details
Table 101. GlaxoSmithKline Business Overview
Table 102. GlaxoSmithKline Diabetes Devices and Drugs Product
Table 103. GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 104. GlaxoSmithKline Recent Development
Table 105. Glenmark Pharmaceuticals Company Details
Table 106. Glenmark Pharmaceuticals Business Overview
Table 107. Glenmark Pharmaceuticals Diabetes Devices and Drugs Product
Table 108. Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 109. Glenmark Pharmaceuticals Recent Development
Table 110. Novartis Company Details
Table 111. Novartis Business Overview
Table 112. Novartis Diabetes Devices and Drugs Product
Table 113. Novartis Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 114. Novartis Recent Development
Table 115. Roche Company Details
Table 116. Roche Business Overview
Table 117. Roche Diabetes Devices and Drugs Product
Table 118. Roche Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 119. Roche Recent Development
Table 120. Sanofi Company Details
Table 121. Sanofi Business Overview
Table 122. Sanofi Diabetes Devices and Drugs Product
Table 123. Sanofi Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 124. Sanofi Recent Development
Table 125. MSD Company Details
Table 126. MSD Business Overview
Table 127. MSD Diabetes Devices and Drugs Product
Table 128. MSD Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 129. MSD Recent Development
Table 130. Astrazeneca Company Details
Table 131. Astrazeneca Business Overview
Table 132. Astrazeneca Diabetes Devices and Drugs Product
Table 133. Astrazeneca Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 134. Astrazeneca Recent Development
Table 135. Takeda Company Details
Table 136. Takeda Business Overview
Table 137. Takeda Diabetes Devices and Drugs Product
Table 138. Takeda Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 139. Takeda Recent Development
Table 140. North China Pharmaceutical Group Corporation Company Details
Table 141. North China Pharmaceutical Group Corporation Business Overview
Table 142. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Product
Table 143. North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 144. North China Pharmaceutical Group Corporation Recent Development
Table 145. Huadong Medicine Company Details
Table 146. Huadong Medicine Business Overview
Table 147. Huadong Medicine Diabetes Devices and Drugs Product
Table 148. Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 149. Huadong Medicine Recent Development
Table 150. Dongbao Pharmaceutical Company Details
Table 151. Dongbao Pharmaceutical Business Overview
Table 152. Dongbao Pharmaceutical Diabetes Devices and Drugs Product
Table 153. Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 154. Dongbao Pharmaceutical Recent Development
Table 155. Hisun Pharmacy Company Details
Table 156. Hisun Pharmacy Business Overview
Table 157. Hisun Pharmacy Diabetes Devices and Drugs Product
Table 158. Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 159. Hisun Pharmacy Recent Development
Table 160. KELUN Company Details
Table 161. KELUN Business Overview
Table 162. KELUN Diabetes Devices and Drugs Product
Table 163. KELUN Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 164. KELUN Recent Development
Table 165. Ginwa Company Details
Table 166. Ginwa Business Overview
Table 167. Ginwa Diabetes Devices and Drugs Product
Table 168. Ginwa Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 169. Ginwa Recent Development
Table 170. Tianan Pharmaceutical Company Details
Table 171. Tianan Pharmaceutical Business Overview
Table 172. Tianan Pharmaceutical Diabetes Devices and Drugs Product
Table 173. Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2016-2021) & (US$ Million)
Table 174. Tianan Pharmaceutical Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Devices and Drugs Market Share by Type: 2020 VS 2027
Figure 2. Diabetes Devices Features
Figure 3. Diabetes Drugs Features
Figure 4. Global Diabetes Devices and Drugs Market Share by Application: 2020 VS 2027
Figure 5. Diagnostic/Clinics Case Studies
Figure 6. ICUs Case Studies
Figure 7. Home Healthcare Case Studies
Figure 8. Diabetes Devices and Drugs Report Years Considered
Figure 9. Global Diabetes Devices and Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Diabetes Devices and Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Diabetes Devices and Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Diabetes Devices and Drugs Market Share by Regions (2022-2027)
Figure 13. Global Diabetes Devices and Drugs Market Share by Players in 2020
Figure 14. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Devices and Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Diabetes Devices and Drugs Revenue in 2020
Figure 16. Global Diabetes Devices and Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Diabetes Devices and Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Diabetes Devices and Drugs Market Share by Type (2016-2027)
Figure 20. North America Diabetes Devices and Drugs Market Share by Application (2016-2027)
Figure 21. North America Diabetes Devices and Drugs Market Share by Country (2016-2027)
Figure 22. United States Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Diabetes Devices and Drugs Market Share by Type (2016-2027)
Figure 26. Europe Diabetes Devices and Drugs Market Share by Application (2016-2027)
Figure 27. Europe Diabetes Devices and Drugs Market Share by Country (2016-2027)
Figure 28. Germany Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Diabetes Devices and Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Diabetes Devices and Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Diabetes Devices and Drugs Market Share by Region (2016-2027)
Figure 38. China Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Diabetes Devices and Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Diabetes Devices and Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Diabetes Devices and Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Diabetes Devices and Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Diabetes Devices and Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Diabetes Devices and Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Diabetes Devices and Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Medtronic Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 58. BD Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 59. Johnson & Johnson Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 60. Abbott Laboratories Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 61. Novo Nordisk Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 63. DexCom Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 64. Companion Medical Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 66. Glenmark Pharmaceuticals Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 68. Roche Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 70. MSD Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 71. Astrazeneca Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 72. Takeda Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 73. North China Pharmaceutical Group Corporation Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 74. Huadong Medicine Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 75. Dongbao Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 76. Hisun Pharmacy Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 77. KELUN Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 78. Ginwa Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 79. Tianan Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の糖尿病治療装置・薬剤市場規模・現状・予測（2021年-2027年） Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs. The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet. Market Analysis an…- 世界の糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a group of metabolic diseases characterized by hyperglycemia. HYPERGLYCEMIA is caused by defective insulin secretion or impaired biological function, or both. The long-term existence of high blood sugar in diabetes leads to chronic damage and dysfunction of various tissues, especially ey…
- 世界の糖尿病管理装置市場規模・現状・予測（2021年-2027年） Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major fact…
- 世界の糖尿病管理市場規模・現状・予測（2021年-2027年） Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level. It occurs due to either inefficiency of pancreases to produce insulin (Type I) or unresponsiveness of body cells to the produced insulin (Type II) or both. This condition sp…
- 世界のミリ波糖尿病治療装置市場 2021：企業別、地域別、種類・用途別 The Millimeter Wave Diabetes Treatment Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…